Jernej Godec is a Principal at Atlas Venture where he focuses on building therapeutics companies and advancing innovative technologies to address major unmet medical needs. He has supported and led investments and company creation efforts across therapeutic areas and has served in Board Director and Board Observer roles at companies including Diagonal Therapeutics, Mariana Oncology, Ethyreal Bio, Triana Biomedicines, and Caldera Therapeutics.

Prior to joining Atlas, Jernej was on the investment team at Apple Tree Partners, where he focused on early-stage therapeutics investments and company formation.

Jernej earned his PhD in immunology from Harvard University, where he studied T cell biology under Arlene Sharpe and Nicholas Haining. He received his B.A. with honors in molecular and cell biology from the University of California, Berkeley. Jernej was also an All-American swimmer and competed in two Olympic Games for Slovenia.